Navigation Links
Oxygen Biotherapeutics, Inc. Expands Board of Directors
Date:10/26/2009

erapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications which are being marketed under the Dermacyte name. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
2. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
3. Oxygen Biotherapeutics, Inc. to Present at Investment Conferences in New York and Zurich
4. Oxygen Biotherapeutics, Inc. Files 10-K for Fiscal Year Ended April 30, 2009
5. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
6. Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
7. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
8. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
9. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
10. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
11. Oxygen Biotherapeutics, Inc. Expands Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... This is ... report provides a basic overview of the industry including definitions, classifications, applications and ... including development trends, competitive landscape analysis, and key regions development status. Development policies ...
(Date:7/27/2015)... 2015 Research presented at the 2015 AACC ... the studies that led to a fingerprick Ebola test ... disease to receive approval from the World Health Organization ... grip on West Africa by ... workers to isolate and treat these patients much faster ...
(Date:7/27/2015)... Junto Health, a company that helps major ... new technology solutions, today announced the launch of a ... in health care policy consulting. Working together with SPG, ... innovation process while, at the same time, they are ... health care finance and the delivery of health care ...
(Date:7/25/2015)... ... ... Technology leader Anton Paar offers the Abbemat T-Check ... of the measuring prism. This is required to achieve the most precise refractive ... requirements. It is likely that no refractometer manufacturers on the market can traceably ...
Breaking Biology Technology:2015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4It’s T-Time for Refractometers: On-site Temperature Check Now Available 2
... October 18 Astex Therapeutics Ltd.,today announced that ... and,AT13148, will be presented at the 2007 AACR-NCI-EORTC ... be held October,22-26, 2007 in San Francisco. ... Kinase (CDK),inhibitor currently in multi-centre Phase 1 clinical ...
... First Combination of Large Molecules to Show Drug-like Properties and ... ... Abbott (NYSE: ABT ),reported today that its scientists ... function and specificity of two or more,monoclonal antibodies (mAbs) into ...
... --, SAN DIEGO, CA, Oct. 18 /PRNewswire-FirstCall/ ... Company,has completed enrollment of the first cohort in ... and tolerability of new HspE7 in patients with,cervical ... to dose up to 5 cohorts comprising twenty-four,patients. ...
Cached Biology Technology:Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 3Abbott Scientists Create One Molecule With Two Antibody Functions 2Abbott Scientists Create One Molecule With Two Antibody Functions 3Nventa updates progress of cervical dysplasia trial with new HspE7 2Nventa updates progress of cervical dysplasia trial with new HspE7 3Nventa updates progress of cervical dysplasia trial with new HspE7 4Nventa updates progress of cervical dysplasia trial with new HspE7 5
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, ... devices with specialties in single use solutions, headquartered in ... MedConx, Inc. (a California corporation with ... San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility in ...
(Date:6/24/2015)... June 24, 2015 The biologics safety testing ... drivers for the market include growth of the pharmaceutical ... drug launches. Over the years, the number of drug ... and 2010, the FDA approved 225 drug applications and ... Europe accounted for 3,822 of ...
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... the embryo. It is here that uniform cells divide ... like skeletal and digestive systems. Although biologists have known ... cell to express certain genes so as to become ... has not been a clear framework explanation of how ...
... State University School of Medicine physician researcher has received ... study the role of vitamin D in halting and ... blood pressure. Phillip Levy, M.D., M.P.H., associate professor ... will use the five-year grant to determine how vitamin ...
... study technique, University of Illinois researchers have seen ... an important family of neurotransmitter-gated ion channels. ... published their work in the journal Nature ... the membranes of nerve and muscle cells that ...
Cached Biology News:From pre-gut cells to glory 2From pre-gut cells to glory 3From pre-gut cells to glory 4Wayne State to study the role of vitamin D in African-Americans with high blood pressure 2Wayne State to study the role of vitamin D in African-Americans with high blood pressure 3Small change makes a big difference for ion channels 2Small change makes a big difference for ion channels 3
... The DNA quantitation kit is used to ... the presence of RNA or protein. With this ... which can be detected with a VersaFluor or ... range of 10 ng per ml to 5 ...
... stimulating factors for assays of mouse hematopoietic ... fetal liver. Suitable for the growth ... when added to methylcellulose at a final ... Will also support growth of mouse ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
...
Biology Products: